Stay updated on Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T16:46:53.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding the details of a clinical study on sacituzumab govitecan for metastatic solid tumors, including key inclusion and exclusion criteria. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    15%
    Check dated 2025-04-16T12:30:52.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 3, 2025.
    Difference
    0.2%
    Check dated 2025-04-09T05:29:44.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.14.3) and a new last update date of March 25, 2025, replacing the previous version (v2.14.2) and date of March 3, 2025.
    Difference
    0.2%
    Check dated 2025-04-01T22:39:17.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The webpage has updated its dates, replacing older ones with new ones for 2025, indicating a shift in the timeline for events or information presented on the page.
    Difference
    1%
    Check dated 2025-03-03T23:00:34.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:23:29.000Z thumbnail image

Stay in the know with updates to Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.